Andrew Spaventa - Dec 15, 2023 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Chief Executive Officer, Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Dec 15, 2023
Transactions value $
$0
Form type
4
Date filed
12/18/2023, 05:39 PM
Previous filing
Nov 20, 2023
Next filing
Feb 13, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +14.6K +149.32% 24.3K Dec 15, 2023 Direct F1
transaction OMIC Common Stock Gift $0 -14.6K -59.89% $0.00 9.77K Dec 15, 2023 Direct F2
transaction OMIC Common Stock Gift $0 +14.6K +0.36% $0.00 4.08M Dec 15, 2023 By The Andrew K. Spaventa Living Trust dated April 9, 2014 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise -14.6K -7.14% 190K Dec 15, 2023 Common Stock 14.6K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Immediately upon vesting of the Reporting Person's RSUs, the Reporting Person transferred his shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
F3 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F4 The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.